2.53
Precedente Chiudi:
$2.65
Aprire:
$2.57
Volume 24 ore:
23,918
Relative Volume:
0.76
Capitalizzazione di mercato:
$13.71M
Reddito:
-
Utile/perdita netta:
$-16.35M
Rapporto P/E:
-0.8295
EPS:
-3.05
Flusso di cassa netto:
$-11.88M
1 W Prestazione:
-8.00%
1M Prestazione:
-24.48%
6M Prestazione:
-24.25%
1 anno Prestazione:
-58.46%
Lipocine Inc Stock (LPCN) Company Profile
Nome
Lipocine Inc
Settore
Industria
Telefono
801 994 7383
Indirizzo
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Confronta LPCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LPCN
Lipocine Inc
|
2.53 | 14.36M | 0 | -16.35M | -11.88M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-06-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-01-12 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-11 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-12-08 | Ripresa | H.C. Wainwright | Buy |
| 2016-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2015-07-22 | Iniziato | ROTH Capital | Buy |
| 2015-06-23 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Lipocine Inc Borsa (LPCN) Ultime notizie
How Lipocine Inc. stock performs after earningsFed Meeting & Real-Time Volume Analysis Alerts - newser.com
Will a bounce in Lipocine Inc. offer an exitTrade Signal Summary & Technical Pattern Alert System - newser.com
Lipocine (NASDAQ: LPCN) shows LPCN 2401 reduces liver fat at 12 weeks, MRI-PDFF data - Stock Titan
Will Lipocine Inc. stock outperform value stocksEarnings Beat & Accurate Technical Buy Alerts - newser.com
Lipocine Presents Promising LPCN 2401 Data at ObesityWeek - TipRanks
Lipocine Inc Presents LPCN 2401 Clinical Data at ObesityWeek® - TradingView
How Lipocine Inc. stock reacts to inflationary pressures2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Will Lipocine Inc. stock go up soonGlobal Markets & Smart Swing Trading Alerts - newser.com
Lipocine Inc expected to post a loss of 54 cents a shareEarnings Preview - TradingView
Why analysts upgrade Lipocine Inc. stockJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Is Lipocine Inc. stock a safe buy before earningsJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
Is Lipocine Inc. stock trading near support levelsEarnings Risk Report & Consistent Return Strategy Ideas - newser.com
How to build a dashboard for Lipocine Inc. stockEarnings Overview Report & Free Technical Pattern Based Buy Signals - newser.com
Smart tools for monitoring Lipocine Inc.’s price actionJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.57 - Markets Mojo
Is Lipocine Inc. stock attractive for long term wealth buildingWeekly Market Summary & Momentum Based Trading Ideas - newser.com
What margin trends mean for Lipocine Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Is Lipocine Inc. stock dividend yield sustainableRecession Risk & Free Fast Entry Momentum Trade Alerts - Fundação Cultural do Pará
How risky is Lipocine Inc. stock now2025 Historical Comparison & Weekly Stock Performance Updates - fcp.pa.gov.br
Lipocine Inc Azioni (LPCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):